Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
McKinney Specialty Labs is an independent, specialty analytical laboratory based in Richmond, Virginia, that provides specialized aerosol testing, chemical analysis, and GLP toxicology services. Launched in January 2024 by Dr. Willie McKinney, the company focuses on testing nicotine and other inhalable products to support regulatory compliance and product development. The lab employs nearly 100 scientists and technicians with expertise in aerosol science, analytical chemistry, and toxicology. It offers a range of services including in vitro potency assays, mutagenicity testing (Ames test), and cytotoxicity assays to help clients navigate global regulatory landscapes. The company is ISO/IEC 17025:2017 accredited and serves a global clientele in the biotechnology, pharmaceutical, and consumer-packaged goods industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on McKinney Specialty Labs.